Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland.
To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field. Multiple system atrophy (MSA) is a neurodegenerative disorder characterised by autonomic dysfunction with parkinsonism (MSAp) or cerebellar (MSAc) symptoms. At autopsy, α-synuclein...
Published in: | Journal of Neurology, Neurosurgery & Psychiatry |
---|---|
Main Authors: | , , , |
Other Authors: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Amer Soc Hematology
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/2336/312623 https://doi.org/10.1136/jnnp-2012-302500 |
Summary: | To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field. Multiple system atrophy (MSA) is a neurodegenerative disorder characterised by autonomic dysfunction with parkinsonism (MSAp) or cerebellar (MSAc) symptoms. At autopsy, α-synuclein inclusions in glial cells of the brain are needed to confirm a definite diagnosis. We determined the 10 year incidence of MSA, point prevalence and survival in a well defined population with a high number of neurologists. Landspitali University Hospital Research Fund |
---|